← Eichor
Condition: Thymic Tumors Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Thymic Tumors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the L
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05354570CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors
Phase N/A · 1 location(s) · European Institute of Oncology · NCT07429851Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07691619An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06730308Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT05672251Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06885697Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06301945Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection
NA · 1 location(s) · Fudan University · NCT02633553PT-112 in Subjects With Thymoma and Thymic Carcinoma
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05104736First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Art
Phase 2 · 1 location(s) · National Cancer Center, Japan · NCT05832827A Study of KC1036 in Patients with Advanced Thymic Tumors
Phase 2 · 2 location(s) · Beijing Konruns Pharmaceutical Co., Ltd. · NCT05683886Hypofractionated Radiotherapy for Thymic Epithelial Tumors
NA · 1 location(s) · Rongrong Zhou · NCT06692062Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapul
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT02146170HEARTS Trial for Thoracic Cancers
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT07132918Molecular Analysis and Treatment Options of Thymic Malignancies
Phase N/A · 1 location(s) · Shanghai Chest Hospital · NCT05667948Serratus Posterior Superior Intercostal Plane Block in Robotic-Assisted Thymectomy
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06545409Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06924619Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03295227Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01950572CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07181720Prospective Data Collection Initiative on Thoracic Malignancies
Phase N/A · 23 location(s) · Dutch Society of Physicians for Pulmonology and Tuberculosis · NCT06996249TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
Phase N/A · 1 location(s) · Tang-Du Hospital · NCT04182984Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06941584A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Phase 2 · 4 location(s) · Georgetown University · NCT06248515Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Phase N/A · 3 location(s) · Universidad Nacional Autonoma de Mexico · NCT06523582Neoadjuvant Treatment For Locally Advanced Thymic Cancer
Phase 2 · 1 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT06019468Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase 2 · 87 location(s) · SWOG Cancer Research Network · NCT05633615Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
NA · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT06141369
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.